Company intelligence / Profile preview

Xceleron

Germantown, Maryland, United Statestracxn.com ↗

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

Xceleron was a pioneering contract research organization specializing in the use of Accelerator Mass Spectrometry (AMS) and ^14C microtracer technology to provide highly sensitive pharmacokinetic and metabolism data during early-stage drug development. Their services enabled pharmaceutical companies to obtain absolute bioavailability data and metabolite safety profiles efficiently, supporting regulatory filings for several approved drugs. The company operated custom-built laboratories in Germantown, Maryland after relocating from York, UK.

Modalities: Small moleculeRadiolabeled compounds
Industry: Contract Research Organization

Partnerships

Provided services to major pharmaceutical and biotechnology companies globally

Beyond the preview

Go deeper on Xceleron.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xceleron.

Explore the full profile